194 related articles for article (PubMed ID: 2323409)
1. Extent of metastatic axillary involvement in 1446 cases of breast cancer.
Veronesi U; Luini A; Galimberti V; Marchini S; Sacchini V; Rilke F
Eur J Surg Oncol; 1990 Apr; 16(2):127-33. PubMed ID: 2323409
[TBL] [Abstract][Full Text] [Related]
2. Lymphatic mapping and sentinel lymphadenectomy in early stage breast carcinoma.
Altinyollar H; Kapucuoglu N; Pak I; Berberoglu U
J Exp Clin Cancer Res; 2000 Jun; 19(2):141-4. PubMed ID: 10965808
[TBL] [Abstract][Full Text] [Related]
3. The pattern of lymphatic metastasis of breast cancer and its influence on the delineation of radiation fields.
Yu J; Li G; Li J; Wang Y
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):874-8. PubMed ID: 15708269
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic options and results for the management of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of T1a and T1b lesions.
White RE; Vezeridis MP; Konstadoulakis M; Cole BF; Wanebo HJ; Bland KI
J Am Coll Surg; 1996 Dec; 183(6):575-82. PubMed ID: 8957459
[TBL] [Abstract][Full Text] [Related]
5. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
[TBL] [Abstract][Full Text] [Related]
6. [Identification of the sentinel node in patients with breast carcinoma].
Nieweg OE; Kapteijn BA; Peterse JL; Rutgers EJ; van Dongen JA; Kroon BB
Ned Tijdschr Geneeskd; 1996 Nov; 140(45):2235-9. PubMed ID: 8984369
[TBL] [Abstract][Full Text] [Related]
7. Extranodal extension of axillary metastasis of invasive breast carcinoma as a possible predictor for the total number of positive lymph nodes.
Palamba HW; Rombouts MC; Ruers TJ; Klinkenbijl JH; Wobbes T
Eur J Surg Oncol; 2001 Dec; 27(8):719-22. PubMed ID: 11735167
[TBL] [Abstract][Full Text] [Related]
8. Metastases to the upper levels of the axillary nodes in carcinoma of the breast and its implications for nodal sampling procedures.
Pigott J; Nichols R; Maddox WA; Balch CM
Surg Gynecol Obstet; 1984 Mar; 158(3):255-9. PubMed ID: 6701738
[TBL] [Abstract][Full Text] [Related]
9. Does the number of lymph nodes examined in patients with lymph node-negative breast carcinoma have prognostic significance?
Salama JK; Heimann R; Lin F; Mehta N; Chmura SJ; Singh R; Kao J
Cancer; 2005 Feb; 103(4):664-71. PubMed ID: 15641038
[TBL] [Abstract][Full Text] [Related]
10. Minimal access breast surgery: a single breast incision for breast conservation surgery and sentinel lymph node biopsy.
Spillane AJ; Brennan ME
Eur J Surg Oncol; 2009 Apr; 35(4):380-6. PubMed ID: 18757165
[TBL] [Abstract][Full Text] [Related]
11. The impact of axillary lymph nodes removed in staging of node-positive breast carcinoma.
Kuru B; Bozgul M
Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1328-34. PubMed ID: 16997505
[TBL] [Abstract][Full Text] [Related]
12. Clinical investigation: regional nodal failure patterns in breast cancer patients treated with mastectomy without radiotherapy.
Strom EA; Woodward WA; Katz A; Buchholz TA; Perkins GH; Jhingran A; Theriault R; Singletary E; Sahin A; McNeese MD
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1508-13. PubMed ID: 16169678
[TBL] [Abstract][Full Text] [Related]
13. Axillary biopsy compared with dissection in the staging of lymph nodes in operable breast cancer. A randomised trial.
Christensen SB; Jansson C
Eur J Surg; 1993 Mar; 159(3):159-62. PubMed ID: 8102890
[TBL] [Abstract][Full Text] [Related]
14. Prospective evaluation of clinical and pathologic detection of axillary metastases in patients with carcinoma of the breast.
Chevinsky AH; Ferrara J; James AG; Minton JP; Young D; Farrar WB
Surgery; 1990 Oct; 108(4):612-7; discussion 617-8. PubMed ID: 2218870
[TBL] [Abstract][Full Text] [Related]
15. [Management of the axilla in breast cancer: evidences and unresolved issues].
Fodor J; Polgár C; Péley G; Németh G
Orv Hetil; 2001 Sep; 142(36):1941-50. PubMed ID: 11680099
[TBL] [Abstract][Full Text] [Related]
16. Breast cancer: risk of axillary recurrence in node-negative patients following partial dissection of the axilla.
Graversen HP; Blichert-Toft M; Andersen JA; Zedeler K
Eur J Surg Oncol; 1988 Oct; 14(5):407-12. PubMed ID: 3181444
[TBL] [Abstract][Full Text] [Related]
17. [Exploration of the extent of axillary dissection for patients with node positive primary breast cancer].
Ouyang T; Li JF; Wang TF; Lin BY
Zhonghua Wai Ke Za Zhi; 2005 Mar; 43(5):298-300. PubMed ID: 15842936
[TBL] [Abstract][Full Text] [Related]
18. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
[TBL] [Abstract][Full Text] [Related]
19. [Histopathological study on the safety of conservative breast surgery in terms of the degree of axillary dissection for breast cancer].
Haga S; Imamura H; Iida T; Watanabe O; Shimizu T; Kajiwara T; Okawa T
Nihon Geka Gakkai Zasshi; 1989 Jun; 90(6):907-13. PubMed ID: 2796961
[TBL] [Abstract][Full Text] [Related]
20. Percent positive axillary lymph node metastasis predicts survival in patients with non-metastatic breast cancer.
Lale Atahan I; Yildiz F; Ozyigit G; Sari S; Gurkaynak M; Selek U; Hayran M
Acta Oncol; 2008; 47(2):232-8. PubMed ID: 17924207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
